Cellular Regulation of Angiotensin Converting Enzyme 2 (ACE2)

血管紧张素转换酶 2 (ACE2) 的细胞调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): Decades of research have established the renin-angiotensin system as a major regulator of blood pressure, homeostasis, and cell proliferation. Renin-angiotensin system effects are mediated by the opposing actions of the peptides angiotensin II (Ang II), a potent vasoconstrictor and mitogen, and angiotensin-(1-7) [Ang-(1- 7)], a vasodilator and growth inhibitor. Angiotensin-converting enzyme 2 (ACE2) recently was identified as a homologue of ACE that preferentially forms Ang-(1-7) from Ang II. Reduced ACE2 expression in the kidney of hypertensive rats suggests its contribution to the balance of Ang II to Ang-(1-7). Although ACE2 was initially localized in peripheral organs such as heart, kidney and testis, we identified ACE2 mRNA and protein in distinct brain regions from both neonatal and adult Sprague-Dawley rats as well as cultured neurons and astrocytes. Further, we demonstrated that treatment of cultured neurons and astrocytes with Ang II caused a marked reduction in ACE2 mRNA and protein. In exciting new results, we showed that inhibition of ACE2 reduced baroreflex control of heart rate, suggesting that the regulation of ACE2 and alterations in the ratio of Ang II to Ang-(1-7) is critical in central control of blood pressure. We propose that ACE2 serves as a major regulator of the balance of Ang ll/Ang-(1-7) concentration in the brain. In Specific Aim 1, we will ascertain whether Ang II regulates ACE2 mRNA and protein in the brain of transgenic rats expressing altered peptide concentrations and whether baroreflex control of heart rate is altered in these rats or following inhibition of ACE2 activity. Studies in Specific Aim 2 will focus on ACE2 secreted from cultured astrocytes, to assess its substrate specificity and determine the molecular mechanism of ACE2 secretion from cultured astrocytes and neurons and from intact brain slices. Finally, in Specific Aim 3, we will identify the transcriptional regulators of ACE2 in astrocytes and neurons. Relevance: ACE2 preferentially converts Ang II to Ang-(1-7), peptides which have opposing actions in the central control of blood pressure. The regulation of ACE2 may be critical to maintaining the normal function of the renin-angiotensin system in the brain.
描述(由申请人提供):几十年的研究已经确定肾素-血管紧张素系统是血压、体内平衡和细胞增殖的主要调节剂。肾素-血管紧张素系统的作用是由肽血管紧张素II (Ang II)和血管紧张素-(1-7)[Ang-(1- 7)]的相反作用介导的,Ang II是一种有效的血管收缩剂和有丝分裂原,Ang-(1- 7)]是一种血管扩张剂和生长抑制剂。血管紧张素转换酶2 (ACE2)最近被发现是ACE的同源物,它优先从Ang II生成Ang-(1-7)。高血压大鼠肾脏中ACE2表达降低提示其参与Ang II与Ang-之间的平衡(1-7)。虽然ACE2最初定位于外周器官,如心脏、肾脏和睾丸,但我们在新生儿和成年Sprague-Dawley大鼠以及培养的神经元和星形胶质细胞的不同脑区发现了ACE2 mRNA和蛋白。此外,我们证明用Ang II处理培养的神经元和星形胶质细胞导致ACE2 mRNA和蛋白的显著降低。在令人兴奋的新结果中,我们发现ACE2的抑制降低了心率的压力反射控制,这表明ACE2的调节和Ang II与Ang-(1-7)比值的改变对血压的中枢控制至关重要。我们认为ACE2是大脑中Ang ll/Ang-(1-7)浓度平衡的主要调节因子。在Specific Aim 1中,我们将确定Ang II是否调节表达改变肽浓度的转基因大鼠大脑中的ACE2 mRNA和蛋白,以及这些大鼠的心率的压力反射控制是否会在ACE2活性抑制后发生改变。Specific Aim 2的研究将重点关注培养的星形胶质细胞分泌的ACE2,评估其底物特异性,并确定培养的星形胶质细胞和神经元以及完整脑切片分泌ACE2的分子机制。最后,在Specific Aim 3中,我们将鉴定星形胶质细胞和神经元中ACE2的转录调节因子。相关性:ACE2优先将Ang II转化为Ang-(1-7),这是一种在血压中枢控制中具有相反作用的肽。ACE2的调控可能对维持大脑肾素-血管紧张素系统的正常功能至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PATRICIA E GALLAGHER其他文献

PATRICIA E GALLAGHER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PATRICIA E GALLAGHER', 18)}}的其他基金

Cellular and Molecular Biology
细胞和分子生物学
  • 批准号:
    8250041
  • 财政年份:
    2011
  • 资助金额:
    $ 27.87万
  • 项目类别:
Cellular and Molecular Biology
细胞和分子生物学
  • 批准号:
    8147919
  • 财政年份:
    2010
  • 资助金额:
    $ 27.87万
  • 项目类别:
Cellular and Molecular Biology Core
细胞和分子生物学核心
  • 批准号:
    7647692
  • 财政年份:
    2009
  • 资助金额:
    $ 27.87万
  • 项目类别:
Core--Cellular and Molecular Biology
核心--细胞与分子生物学
  • 批准号:
    7386021
  • 财政年份:
    2007
  • 资助金额:
    $ 27.87万
  • 项目类别:
Cellular Regulation of Angiotensin Converting Enzyme 2
血管紧张素转换酶 2 的细胞调节
  • 批准号:
    7147150
  • 财政年份:
    2006
  • 资助金额:
    $ 27.87万
  • 项目类别:
Core--Cellular and Molecular Biology
核心--细胞与分子生物学
  • 批准号:
    7218016
  • 财政年份:
    2006
  • 资助金额:
    $ 27.87万
  • 项目类别:
Cellular Regulation of Angiotensin Converting Enzyme 2 (ACE2)
血管紧张素转换酶 2 (ACE2) 的细胞调节
  • 批准号:
    7269294
  • 财政年份:
    2006
  • 资助金额:
    $ 27.87万
  • 项目类别:
Cellular Regulation of Angiotensin Converting Enzyme 2 (ACE2)
血管紧张素转换酶 2 (ACE2) 的细胞调节
  • 批准号:
    7619089
  • 财政年份:
    2006
  • 资助金额:
    $ 27.87万
  • 项目类别:
Core--Cellular and Molecular Biology
核心--细胞与分子生物学
  • 批准号:
    7063101
  • 财政年份:
    2005
  • 资助金额:
    $ 27.87万
  • 项目类别:
Core--Cellular and Molecular Biology
核心--细胞与分子生物学
  • 批准号:
    6853124
  • 财政年份:
    2004
  • 资助金额:
    $ 27.87万
  • 项目类别:

相似海外基金

Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
  • 批准号:
    493141
  • 财政年份:
    2023
  • 资助金额:
    $ 27.87万
  • 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
  • 批准号:
    10734120
  • 财政年份:
    2023
  • 资助金额:
    $ 27.87万
  • 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
  • 批准号:
    10707997
  • 财政年份:
    2022
  • 资助金额:
    $ 27.87万
  • 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
  • 批准号:
    RGPIN-2016-04414
  • 财政年份:
    2022
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
  • 批准号:
    10555926
  • 财政年份:
    2022
  • 资助金额:
    $ 27.87万
  • 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
  • 批准号:
    RGPIN-2016-04414
  • 财政年份:
    2021
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
  • 批准号:
    445961
  • 财政年份:
    2021
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
  • 批准号:
    10164776
  • 财政年份:
    2020
  • 资助金额:
    $ 27.87万
  • 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
  • 批准号:
    10251271
  • 财政年份:
    2020
  • 资助金额:
    $ 27.87万
  • 项目类别:
Protection and organ injury by angiotensin II treatment for septic shock
血管紧张素II治疗感染性休克的保护作用和器官损伤
  • 批准号:
    20K09284
  • 财政年份:
    2020
  • 资助金额:
    $ 27.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了